Augmented levels of angiogenic cytokines as VEGF, soluble vascular endothelial growth factor receptors 1 and 2, and placenta growth factor, as well as the increased number of endothelial cells and endothelial precursors are associated with high risk of thrombotic events in ET and PV patients (59). The gene discussed is PGF; the disease is acquired polycythemia vera.